Bridelia Retusa

Bridelia retusa  (Linn.) Spreng.

1. Taxonomic, Nomenclature & Therapeutic Summary Table

Botanical Attribute Pharmacognostic & Therapeutic Specification
Family Euphorbiaceae.
Habitat Throughout India up to an altitude of 1,000 m, except in very dry regions.
Ayurvedic Mahaaviraa, Asana (Asana is equated with Pterocarpus marsupium Roxb., the Indian Kino tree.)
Siddha / Tamil Mulluvengai.
Folk Gondani, Gondui, Khaajaa.
Action Bark—astringent, used in the form of a liniment in rheumatism. Paste of the stem bark is applied to wounds.
Taxonomic Cohort Genus Bridelia (2 documented species); Family Euphorbiaceae (50 documented species).

2. Classical Nomenclature, Taxonomy & Biogeographical Context

Bridelia retusa (taxonomically cited with authority (Linn.) Spreng.) is an established medicinal plant species in Indian materia medica. It is classified under the botanical family Euphorbiaceae (primary family classification: Euphorbiaceae), placing it within a well-defined chemotaxonomic group of medicinal flora. Within botanical taxonomy, this taxon is cataloged directly under its primary accepted binomial without secondary botanical synonyms. Biogeographically, its documented habitat and ecological distribution span: Throughout India up to an altitude of 1,000 m, except in very dry regions.

Across classical and vernacular Indian systems of medicine, Bridelia retusa is recognized under distinct polyglot nomenclature: in the Ayurvedic system (synchronized across The Ayurvedic Pharmacopoeia of India, CCRAS Standard Nomenclature, Sharangadhara Samhita, and Bhava Prakash) as Mahaaviraa, Asana (Asana is equated with Pterocarpus marsupium Roxb., the Indian Kino tree.); in the Siddha and Tamil medical tradition (compiled from the Formulary of Siddha Medicine and IMPCOPS Chennai) as Mulluvengai; in regional Indian folk and vernacular ethnobotany as Gondani, Gondui, Khaajaa. Romanized Sanskrit and Ayurvedic spellings follow standard National Academy of Ayurveda (Rashtriya Ayurveda Vidyapeeth) transliteration conventions, using double vowels to preserve authentic classical pronunciation across regional medical traditions.

3. Therapeutic Actions, Phytochemistry & Pharmacological Profile

In therapeutic and clinical pharmacognosy, the primary recorded actions and clinical indications of Bridelia retusa are: Bark—astringent, used in the form of a liniment in rheumatism. Paste of the stem bark is applied to wounds. These traditional and clinical attributes reflect the plant part-specific pharmacological profile documented across classical Indian treatises and modern herbal pharmacopoeias.

Experimental phytochemistry, active chemical constituents, and pharmacological screening studies reported for Bridelia retusa establish the following evidence base: The bark contains 16–40% tannin. Presence of a triterpene ketone in the bark is reported. The bark exhibited hypotensive properties in pharmacological trials. The extract of the bark significantly increased the mean survival time of mice infected intracerebrally with vaccinia virus. Ripe fruit pulp contains beta-sitosterol and gallic and ellagic acids.

image2

Botanical Reference 1: Bridelia retusa — Botanical specimen

image3

Botanical Reference 2: Bridelia retusa — Botanical specimen

image3

Botanical Reference 3: Bridelia retusa — Wikimedia Commons reference

4. Comparative Genus & Family Pharmacognosy

Taxonomically, the genus Bridelia comprises 2 distinct medicinal species in Indian herbal literature. Closely allied congeneric species include: Bridelia montana (Action: Bark and Root—astringent, anthelmintic. Used in the treatment of bone fracture….). Comparing Bridelia retusa alongside its congeners in genus Bridelia highlights both shared secondary metabolite classes and species-specific organotropism across different ecological zones.

At the family level, Euphorbiaceae encompasses 50 documented medicinal species (2.76% of the 1,814-species flora). Other representative medicinal members of Euphorbiaceae include: Acalypha ciliata (Kuppi), Acalypha fruticosa (Birch-leaved Acalypha), Acalypha indica (Kuppi), Aleurities moluccana (Akshota), Baliospermum montanum (Danti). In comparative pharmacognosy, evaluating species within the same botanical family aids quality control, authentication of crude drugs, and identification of chemotaxonomic markers.

image1

Figure 1: Quantitative documentation profile across all 50 medicinal species of family Euphorbiaceae.

5. Pharmacopoeial Standards, Posology & Reference Framework

In clinical and traditional dispensing, preparation and administration of Bridelia retusa follow the plant-part modalities specified under its therapeutic action (Bark—astringent, used in the form of a liniment in rheumatism. Paste of the stem bark is applied to wounds), guided by the standard posological principles of The Ayurvedic Pharmacopoeia of India (Vols. I–IV) and CCRAS formularies. Classical and modern pharmacognostic synchronization for Bridelia retusa integrates standards from The Ayurvedic Pharmacopoeia of India, The National Formulary of Unani Medicine, Formulary of Siddha Medicine, The Wealth of India (CSIR), Compendium of Indian Medicinal Plants (CDRI), Dictionary of Indian Medicinal Plants (CIMAP), German Commission E, ESCOP, WHO monographs, British Herbal Pharmacopoeia, and Natural Medicines Comprehensive Database.

Scroll to Top